A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication. Moon C, Porges E, Roberts A, Bacon J, et al. Antiviral Res 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.

Read + Share

Amedeo Smart

Independent Medical Education

Moon C, Porges E, Roberts A, Bacon J, et al. A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication. Antiviral Res 2024 Mar 14:105859. doi: 10.1016/j.antiviral.2024.105859.
PMID: 38492891